Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia
Clinical trial NCT03156842 · COMPLETED
Trial details
- NCT number
- NCT03156842
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-29
- Primary completion
- 2018-12-07
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.